NEUROGENE INC (NGNE) Stock Balance Sheet
NASDAQ:NGNE - Nasdaq - US64135M1053 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 66.63M | 148.21M | 37.90M | 142.50M | 192.60M | |||
| Marketable Securities | 72.36M | 48.95M | 58.50M | N/A | N/A | |||
| Receivables | 672.00K | N/A | N/A | N/A | 900.00K | |||
| Other Current Assets | 3.98M | 3.19M | 2.80M | 1.50M | 1.10M | |||
| Total Current Assets | 143.65M | 200.35M | 99.10M | 144.00M | 194.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 19.34M | 20.95M | 15.90M | 17.20M | 13.70M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | N/A | N/A | 0.00 | 100.00K | 300.00K | |||
| Other Non-Current Assets | 1.13M | 1.27M | 900.00K | 1.90M | 1.90M | |||
| Total Non-Current Assets | 20.47M | 22.23M | 16.80M | 19.30M | 16.00M | |||
| TOTAL ASSETS | 164.12M | 222.57M | 115.90M | 163.30M | 210.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 54.00K | 42.00K | 100.00K | 100.00K | 0.00 | |||
| Accrued Expenses | 12.77M | 20.05M | 10.40M | 8.10M | 6.50M | |||
| Accounts Payable | 1.68M | 2.60M | 500.00K | 500.00K | 1.30M | |||
| Other Current Liabilities | 1.29M | 281.00K | N/A | N/A | N/A | |||
| Total Current Liabilities | 15.80M | 22.97M | 11.10M | 8.60M | 7.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 39.00K | 65.00K | 200.00K | 100.00K | 100.00K | |||
| Other Non-Current Liabilities | 10.87M | 13.51M | 10.30M | 11.70M | 11.30M | |||
| Total Non-Current Liabilities | 10.91M | 13.58M | 10.50M | 11.80M | 11.40M | |||
| TOTAL LIABILITIES | 26.71M | 36.55M | 21.60M | 20.40M | 19.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -242.78M | -187.15M | -451.10M | -393.50M | -332.80M | |||
| Additional Paid In Capital | 380.20M | 373.18M | 545.40M | 536.40M | 524.00M | |||
| Common Shares | 10.00 | 10.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -10.00 | -10.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 13.01M | 12.82M | 1.70M | 1.70M | 1.70M | |||
| Tangible Book Value per Share | 10.56 | 14.51 | 55.47 | 84.00 | 112.29 | |||
| Total Shareholders' Equity | 137.41M | 186.02M | 94.30M | 142.90M | 191.20M | |||
| TOTAL LIABILITIES AND EQUITY | 164.12M | 222.57M | 115.90M | 163.30M | 210.50M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Ratio | 9.09 | 8.72 | 8.93 | 16.74 | 24.62 | |||
| Return On Assets (ROA) | -43.34% | -16.32% | -49.66% | -37.16% | -15.81% | |||
| Return On Equity (ROE) | -51.76% | -19.52% | -61.04% | -42.47% | -17.41% | |||
All data in USD , ROIC based on taxRate of 0.21